IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 231 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $564,292 | -79.1% | 53,035 | -79.3% | 0.05% | -71.5% |
| Q1 2023 | $2,700,000 | +9.4% | 256,654 | +28.9% | 0.16% | +1.9% |
| Q4 2022 | $2,467,345 | +32.3% | 199,140 | +10.6% | 0.16% | +32.8% |
| Q3 2022 | $1,865,000 | +44.5% | 179,975 | +60.7% | 0.12% | +79.4% |
| Q2 2022 | $1,291,000 | +38.8% | 111,999 | +57.3% | 0.07% | +30.8% |
| Q3 2021 | $930,000 | -22.0% | 71,214 | -23.1% | 0.05% | -18.8% |
| Q2 2021 | $1,192,000 | +35.9% | 92,642 | +18.1% | 0.06% | +28.0% |
| Q1 2021 | $877,000 | -15.1% | 78,453 | -13.5% | 0.05% | -33.3% |
| Q4 2020 | $1,033,000 | -59.7% | 90,657 | -68.2% | 0.08% | -9.6% |
| Q3 2020 | $2,566,000 | -18.6% | 285,308 | -6.6% | 0.08% | +2.5% |
| Q2 2020 | $3,154,000 | +907.7% | 305,593 | +885.2% | 0.08% | +912.5% |
| Q1 2020 | $313,000 | – | 31,017 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |